Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity

Sorafenib and regorafenib are tyrosine kinase inhibitors that are used in the treatment of hepatocellular carcinoma and which have similar chemical structures and toxicity profiles. We herein report a case in which regorafenib treatment could be continued for 10 months and stable disease could be ma...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Intern Med
Main Authors: Yoshioka, Naoki, Kuzuya, Teiji, Ito, Takanori, Ishizu, Yoji, Honda, Takashi, Ishikawa, Tetsuya, Ishigami, Masatoshi, Fujishiro, Mitsuhiro
Formato: Artigo
Idioma:Inglês
Publicado: The Japanese Society of Internal Medicine 2019
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6815910/
https://ncbi.nlm.nih.gov/pubmed/31243207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2812-19
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares